Contact Information
37 Westminster Buildings, Theatre Square,
Nottingham, NG1 6LG
Here’s a New Million-Dollar Reason to Buy CRISPR Therapeutics
CRISPR Therapeutics (NASDAQ: CRSP) is heading for an important moment: the potential approval of its first product, exa-cel to treat blood disorders. That’s a good
Unusual Call Option Trade in Viking Therapeutics (VKTX) Worth $659.70K
On March 31, 2023 at 14:16:36 ET an unusually large $659.70K block of Call contracts in Viking Therapeutics (VKTX) was bought, with a strike price
Ra Capital Management Now Owns 16.10% of DICE Therapeutics (DICE)
Fintel reports that Ra Capital Management has filed a 13D/A form with the SEC disclosing ownership of 7.66MM shares of DICE Therapeutics Inc (DICE). This
Evercore ISI Group Initiates Coverage of Astria Therapeutics (ATXS) with Outperform Recommendation
On March 28, 2023, Evercore ISI Group initiated coverage of Astria Therapeutics with a Outperform recommendation. Analyst Price Forecast Suggests 114.24% Upside As of March
B of A Securities Initiates Coverage of Foghorn Therapeutics (FHTX) with Buy Recommendation
On March 28, 2023, B of A Securities initiated coverage of Foghorn Therapeutics with a Buy recommendation. Analyst Price Forecast Suggests 254.32% Upside As of